BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 28, 2003
View Archived Issues
ET-743 is associated with changes in the gene expression of sarcoma cells
Read More
Preliminary phase I results on EKB-569 for advanced colorectal cancer
Read More
Potential use of SB-277011-A in preventing relapse to cocaine abuse
Read More
BP-897 ameliorates dyskinesia induced by levodopa in PD
Read More
CeNeS strengthens CNS pipeline through acquisition of TheraSci
Read More
ELITE trial studies TOBI for early-onset P. aeruginosa in cystic fibrosis
Read More
New pivotal Synvisc trial to expand U.S. label
Read More
Enrollment completed in phase II Veronate study
Read More
Sinovac seeks approval to advance SARS vaccine into clinical testing
Read More
WHO collaborates with Acambis on ChimeriVax-JE development
Read More
Orphan drug status for Advanced Biotherapy antibodies targeting interferon gamma
Read More
Antisoma and EMD Lexigen create immunocytokine fusion protein
Read More
BioInvent acquires proteins for development of osteoarthritis therapeutic
Read More
Introgen and SWOG to evaluate Advexin plus surgery in phase II trial
Read More
Novel 5-HT2C ligands and their use reported by GSK researchers
Read More
Enanta presents two series of antibacterial macrolides
Read More
New thrombin receptor antagonists prepared and tested at Schering
Read More
Schering researchers describe new histamine H3 antagonists and their use
Read More
Bayer scientists design new hypoglycemic and hypolipidemic agents
Read More
Novel agents for cytomegalovirus infection discovered at Bayer
Read More
Potent analgesic activity and favorable safety profile reported for new nAChR agonist
Read More
Plenaxis receives FDA approval
Read More
Liver histology improvements in phase III study of emtricitabine for hepatitis B
Read More
P2X3 receptor antagonist INS-48506 is a potent analgesic in rodent models
Read More
Salix submits amendment to NDA for rifaximin
Read More
Schering-Plough takes option to license intranasal pleconaril rights
Read More
Atypical anxiolytic JNJ-5234801 may be effective at doses not associated with CNS side effects
Read More
Improved hemodynamic profile for new iron-containing hematinic agent ABT-870
Read More
New drug candidate activates CREB function and ameliorates long-term memory
Read More